Home PRISM BioLab

PRISM BioLab

In operation
Series C
Non-Oncology Indication Therapeutics Supplier
Basic
Enterprise Profile

Basic Information

PRISM is a supplier of therapeutic drugs for non-oncology indications. The company develops treatments for pulmonary fibrosis, cancer, and incurable diseases. PRISM leverages our unique peptidomimetic technology to develop drugs targeting these challenging conditions.
PRISM BioLab Co., Ltd.
Kanagawa,Japan
15~50 people
November 02, 2006
--

Enterprise Profile

Industrial Sector
Compound Discovery New Drug Development Manufacture of Chemical Pharmaceutical Preparations
Technology
Biotechnology
Concept
Therapeutic Products
Application Scenarios
Chemical Drug Innovative Drugs